Gelonghui October 23rd丨Bide Pharmaceutical (688073.SH) announced that the company's revenue for the first three quarters was 0.811 billion yuan, a year-on-year increase of 0.79%; the net income attributable to the shareholders of the listed company was 83.8539 million yuan, a year-on-year decrease of 26.05%; the net income attributable to the shareholders of the listed company excluding non-recurring gains and losses was 72.3904 million yuan, a year-on-year decrease of 40.18%; basic earnings per share was 0.94 yuan.